Dublin, May 07, 2020 (GLOBE NEWSWIRE) -- The "Wound Closure & Advanced Wound Care Global Market - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
The wound closure and advanced wound care global market is expected to reach $25,527.8 million by 2026 growing at a mid single digit CAGR from 2019 to 2026, due to increasing prevalence of acute and chronic wounds, escalating number of surgical procedures associated with highly prevalent lifestyle and chronic diseases, rapidly increasing geriatric population, increasing demand for highly efficient, scarless and sophisticated wound management products from the value-centric patient population, increasing R&D spending for developing innovative and technologically advanced products, growing economies and increasing demand for better healthcare facilities in emerging markets. The wound closure and advanced wound care market is segmented by wound type, product, application, end-user and geography.
The Asia-Pacific is the fastest-growing region in wound closure and advanced wound care market in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2026 due to elevating acute and chronic wounds burden in the region, escalating number of surgical procedures associated with highly prevalent chronic diseases, increasing geriatric population, increasing demand for better healthcare facilities, increasing penetration of reimbursement schemes in developing countries, elevating demand for better healthcare facilities from the population in the region, growing economies of the region, availability of various kinds of wound management products and increasing patient awareness of these products and increasing medical tourism prospects of the region.
The wound closure and advanced wound care global market is fragmented without a dominant major player in the market that offers lots of opportunities for low barrier entry for small and medium-sized companies with distinct products in the market. Some of the major players in wound closure and advanced wound care market include Medtronic PLC (Ireland), 3M Company (U.S.), Smith & Nephew PLC (U.K.), Johnson & Johnson (J&J) (U.S.), Baxter International Inc. (U.S.), Molnlycke Holding AB (Sweden), Convatec Inc. (U.K.), Paul Hartmann AG (Germany), Integra LifeSciences Corporation (U.S.), Cardinal Health Inc. (U.S.), B. Braun Melsungen AG (Germany), Coloplast Group (Denmark) and others.
Key Topics Covered:
1 Executive Summary
2 Introduction
2.1 Key Takeaways
2.2 Scope of the Report
2.3 Report Description
2.4 Markets Covered
2.5 Stakeholders
2.6 Research Methodology
2.6.1 Market Size Estimation
2.6.2 Market Breakdown and Data Triangulation
2.6.3 Secondary Sources
2.6.4 Primary Sources
2.6.5 Key Data Points from Secondary Sources
2.6.6 Key Data Points from Primary Sources
2.6.7 Assumptions
3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers and Opportunities
3.3.1.1 Increasing Prevalence of Acute and Chronic Wounds
3.3.1.2 Increase in Surgical Procedural Volume
3.3.1.3 Elevating Demand for Biologics in Wound Care
3.3.1.4 Emergence of Technically Advanced Products
3.3.1.5 Increase in Aging Population and Prevalence of Lifestyle Diseases
3.3.1.6 Acquisitions to Open An Array of Opportunities for the Market to Flourish
3.3.2 Restraints and Threats
3.3.2.1 Lack of Professionals in Handling the Sophisticated Advanced Wound Closure and Wound Care Techniques
3.3.2.2 High Cost of Advanced Wound Closure and Wound Care Devices
3.3.2.3 Adverse Effects of Wound Closure and Wound Care Devices
3.3.2.4 Unfavorable Reimbursement Policies in Developing Nations
3.3.2.5 Stringent Regulatory Bodies Guiding the Wound Closure and Advanced Wound Care Manufacturers
3.3.2.6 Increasing Preference for Minimally Invasive Surgeries
3.4 Regulatory Affairs
3.4.1 International Organization for Standardization
3.4.1.1 ISO 9001: 2015 Quality Management System
3.4.1.2 ISO 13485 Medical Devices
3.4.1.3 ISO 10993 Biological Evaluation of Medical Devices
3.4.1.4 ISO 14971 Risk Management of Medical Devices
3.4.1.5 IEC 60601-1 Medical Electrical Equipment Standard
3.4.1.6 IEC 60601-1-11 Home Care Safety
3.4.2 Astm International Standards
3.4.3 U.S.
3.4.4 Canada
3.4.5 Europe
3.4.6 Japan
3.4.7 China
3.4.8 India
3.5 Clinical Trials
3.6 Technological Advancements
3.6.1 Nanoparticle Based Wound Healing
3.6.2 Smart Wound Dressings
3.6.3 Gene Therapy
3.6.4 3D Bioink Printer
3.6.5 Bioactive Glasses in Wound Repair
3.6.6 Stem Cell Technology
3.6.7 Biochips for Wound Healing
3.6.8 Micro Anchor Technology
3.7 Porter'S Five Force Analysis
3.7.1 Threat of New Entrants
3.7.2 Threat of Substitutes
3.7.3 Bargaining Power of Suppliers
3.7.4 Bargaining Power of Buyers
3.7.5 Competitive Rivalry
3.8 Supply Chain Analysis
3.9 Reimbursement Scenario
3.10 Funding Scenario
3.11 Biomaterials
3.12 Single Use V/S Reusable Devices
3.13 Market Share Analysis by Major Players
3.13.1 Wound Closure and Advanced Wound Care Global Market Share Analysis
3.13.2 Sealants, Adhesives and Hemostats Global Market Share Analysis
3.13.3 Advanced Wound Dressings Global Market Share Analysis
3.13.4 Negative Pressure Wound Therapy (NPWT) Global Market Share Analysis
3.13.5 Engineered Skin Substitutes and Biologics Global Market Share Analysis
3.14 Wound Closure and Advanced Wound Care Company Comparison Table by Product Type, Product Name and Application
3.14.1 Wound Closure Devices
3.14.2 Sealants, Adhesives and Haemostats
3.14.3 Wound Care Devices
3.14.4 Biologics and Advanced Wound Dressings
4 Wound Closure and Advanced Wound Care Global Market, by Wound Type
4.1 Introduction
4.2 Acute Wound
4.3 Chronic Wound
5 Wound Closure and Advanced Wound Care Global Market, by Product
5.1 Introduction
5.2 Wound Closure and Wound Care Devices
5.2.1 Sutures
5.2.1.1 Sutures by Operational Mode
5.2.1.1.1 Manual Sutures
5.2.1.1.2 Automated Suturing Devices
5.2.1.2 Sutures by Material Type
5.2.1.2.1 Absorbable Sutures
5.2.1.2.2 Non-Absorbable Sutures
5.2.2 Wound Closure Strips
5.2.3 Staples
5.2.4 Ligating Clips
5.2.5 Negative Pressure Wound Therapy (NPWT)
5.2.6 Hyperbaric Oxygen Therapy (Hot)
5.2.7 Energy Based Devices
5.3 Advanced Wound Closure and Biologics
5.3.1 Sealants and Adhesives
5.3.1.1 Natural Sealants and Adhesives
5.3.1.1.1 Collagen Sealants and Adhesives
5.3.1.1.2 Albumin Sealants and Adhesives
5.3.1.1.3 Gelatin Sealants and Adhesives
5.3.1.1.4 Fibrin Sealants and Adhesives
5.3.1.1.5 Other Natural Sealants and Adhesives
5.3.1.2 Synthetic Sealants and Adhesives
5.3.1.2.1 Cyanoacrylate Sealants and Adhesives
5.3.1.2.2 Hydrogels Sealants and Adhesives
5.3.1.2.3 Other Synthetic Sealants and Adhesives
5.3.2 Haemostats
5.3.2.1 Mechanical Haemostats
5.3.2.2 Active Haemostats
5.3.2.3 Flowable Haemostats
5.3.2.4 Fibrin Haemostats
5.3.3 Engineered Skin Substitutes
5.3.4 Growth Factors
5.4 Advanced Wound Dressing
5.4.1 Foam Dressing
5.4.2 Hydrocolloid Dressing
5.4.3 Film Dressing
5.4.4 Antimicrobial Dressing
5.4.5 Hydrogel Dressing
5.4.6 Other Advanced Wound Dressing
6 Wound Closure and Advanced Wound Care Global Market, by Application
6.1 Introduction
6.2 Burns
6.3 Ulcers
6.3.1 Pressure Ulcers
6.3.2 Venous Leg Ulcers
6.3.3 Diabetic Foot Ulcers
6.3.4 Arterial Ulcers
6.4 Surgical Wounds
6.5 Traumatic Lacerations
6.6 Radionecrosis
7 Wound Closure and Advanced Wound Care Global Market, by End-User
7.1 Introduction
7.2 Hospitals and ASC
7.3 Clinics and Community Healthcare Services
7.4 Other End-User
8 Regional Analysis
8.1 Introduction
8.2 North America
8.3 Europe
8.4 APAC
8.5 RoW
9 Competitive Landscape
9.1 Introduction
9.2 Product Launch
9.3 Acquisition
9.4 Product Approval
9.5 Partnerships and Expansions
9.6 Others
10 Major Companies
10.1 3M Company
10.1.1 Overview
10.1.2 Financials
10.1.3 Product Portfolio
10.1.4 Key Developments
10.1.5 Business Strategy
10.1.6 SWOT Analysis
10.2 Baxter International, Inc.
10.3 B. Braun Melsungen AG
10.4 Cardinal Health Inc.
10.5 Coloplast Group
10.6 Convatec Inc.
10.7 Integra Lifesciences Holdings Corporation
10.8 Johnson & Johnson (Ethicon)
10.9 Medtronic Public Limited Company
10.10 Molnlycke Holding Ab
10.11 Paul Hartmann AG
10.12 Smith & Nephew plc
Companies Mentioned
- 3M Company
- A&E Medical Corporation
- Abigo Medical
- Acell Inc.
- Ackermann Instrumente GmbH
- Ad Surgical
- Adhesive Research, Inc.
- Adhesys Medical GmbH
- Adhezion Biomedical LLC
- Advanced Biohealing
- Advanced Medical Solutions Group plc
- Advancis Medical
- Adynxx, Inc.
- Aedicell Inc.
- Akacia Medical (Pty) Ltd. (Clinisut)
- Alca Trgovina D.O.O
- Anodyne Therapy LLC
- Apollo Endosurgery Inc.
- Arobella Medical LLC
- Assut Medical Sarl
- Atramat
- Avery Dennison Corporation
- Axio Biosolutions Private Limited
- B. Braun Melsungen AG
- Baxter International Inc.
- Bear Medic Corporation
- Becton, Dickinson and Company (C.R. Bard Inc.)
- Bentley Healthcare Pvt. Ltd
- Bsn Medical GmbH
- Cardinal Health Inc.
- Chemence Medical Inc.
- Cohera Medical Inc.
- Coloplast Group
- Conmed Corporation
- Connexicon Medical Ltd
- Convatec Inc.
- Coopersurgical Inc.
- Covalon Technologies Ltd.
- CP Medical
- Cryolife Inc.
- Demetech Corporation
- Deroyal Industries, Inc
- Dogsan
- Dolphin Sutures
- Dukal Corporation
- Dynek Pty Ltd.
- Elite Surgical Supplies (Pty) Ltd
- Emerson Worldwide
- Encompass Health
- Eurofarm S.P.A
- Fink Engineering Pty Ltd
- Frankenman International Limited
- Gelita Medical
- Gem Srl
- Genadyne Biotechnologies, Inc.
- Glustitch Inc
- Gordian Surgical Ltd.
- Grena Ltd
- Gulf Coast Hyperbaric Inc.
- Gunze Ltd
- Healthium Ltd. (Sutures India)
- Hemostasis LLC
- Hipertech Inc.
- HLL Lifecare Limited
- Hollister Incorporated
- Human Biosciences Inc.
- Hydrofera, LLC
- IHC Hytech
- Integra Lifesciences Corporation
- Johari Digital Healthcare Ltd.
- Johnson & Johnson (Ethicon)
- Kerecis
- Kono Seisakusho Co. Ltd.
- Laboratoires Brothier
- Laserneedle GmbH
- Lifenet Health Inc.
- Logimex Brasil Ltda
- Lohmann & Rauscher GmbH & Co. Kg
- Lotus Surgicals Pvt Ltd
- Lsi Solutions Inc.
- Mallinckrodt plc
- Mani Inc.
- Medela AG
- Mediwound Ltd.
- Medline Industries Inc.
- Medskin Solutions Dr. Suwelack AG
- Medtronic plc
- Meyer-Haake GmbH
- Mimedx Group Inc.
- Misonix Inc.
- Molnlycke Holding Ab
- Nantong Holycon Medical Equipment Co. Ltd.
- Nuo Therapeutics Inc.
- Organogenesis Holdings Inc.
- Owens & Minor Inc.
- Oxyhealth LLC.
- Paul Hartmann AG
- Perry Baromedical
- Peters Surgical
- Plastod S.P.A
- Prospera Technologies LLC
- Purple Surgicals
- Qingdao Kingston Medical Devices Co.
- S. Jackson Inc.
- Samyang Biopharmaceuticals
- Sanitex S.P.A
- Sechrist Industries, Inc.
- Sis Manufacturing Ltd.
- Smb Corporation of India
- Smith & Nephew plc
- Stryker Corporation (Zipline Medical)
- Talley Group Ltd
- Tavtech Ltd.
- Teleflex Incorporated
- Theragenics Corporation
- Tissue Regenix Group plc
- Tissueseal LLC
- Tricol Biomedical Inc. (Hemcon Medical Technologies)
- Unik Surgical Sutures Mfg
- Urgo Group
- Vomaris Innovations Inc.
- Wego Newlife Medical Devices
- Winner Medical Group Inc.
- Zhejiang Longterm Medical Technology Co Ltd (Innomed)
- Zhejiang Top Medical, Changchun Ja Biotech
- Zimmer Biomet
For more information about this report visit https://www.researchandmarkets.com/r/hm7b0d
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.